PSquared Asset Management AG Quant / Systematic

Location: Zurich, Switzerland

CIK: 0001623624 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value: $607M (100.0% shares, 0.0% debt)

Holdings (7)

— CYPRESS SEMICONDUCTOR CORP 32.2%

Value $195M Shares 8,375,800 Est. Cost $22.62 Unrealized —

— VERSUM MATERIALS INC. 24.0%

Value $146M Shares 2,750,203 Est. Cost $51.77 Unrealized —

— ALLERGAN PLC 21.8%

Value $133M Shares 787,556 Est. Cost $168.29 Unrealized —

— ZAYO GROUP HLDGS INC 11.7%

Value $71.02M Shares 2,094,930 Est. Cost $33.42 Unrealized —

— SPARK THERAPEUTICS INC 4.3%

Value $26.18M Shares 270,000 Est. Cost $96.98 Unrealized —

— MEDIDATA SOLUTIONS INC 3.2%

Value $19.62M Shares 214,398 Est. Cost $91.50 Unrealized —

— WABCO HLDGS INC 2.7%

Value $16.34M Shares 122,177 Est. Cost $133.75 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	CYPRESS SEMICONDUCTOR CORP	8,375,800	$195M	32.2%	$22.62	—	COM	232806109
—	VERSUM MATERIALS INC.	2,750,203	$146M	24.0%	$51.77	—	COM	92532W103
—	ALLERGAN PLC	787,556	$133M	21.8%	$168.29	—	SHS	G0177J108
—	ZAYO GROUP HLDGS INC	2,094,930	$71.02M	11.7%	$33.42	—	COM	98919V105
—	SPARK THERAPEUTICS INC	270,000	$26.18M	4.3%	$96.98	—	COM	84652J103
—	MEDIDATA SOLUTIONS INC	214,398	$19.62M	3.2%	$91.50	—	COM	58471A105
—	WABCO HLDGS INC	122,177	$16.34M	2.7%	$133.75	—	COM	92927K102